EuroPCR 2023 Hotlines / Late-Breaking Trials: TAVI

Session comprising selected EuroPCR 2023 Late-Breaking Trial submissions

Anchorperson: D. Mylotte

Spokesperson: R. Mehran

Summary

Discover the conclusions of various studies and registries about TAVI: 5-year outcomes with the ACURATE neo2 valve: the Neo AS CE-mark study; TAVR in patients with cardiogenic shock which evaluated outcomes of consecutive TAVRs in patients with CS using contemporary SAPIEN 3 and SAPIEN 3 ultra balloon expandable valves; 5-year outcomes for TAVI with an intra-annular, self-expandable bioprosthesis; Chimney stenting vs BASILICA to prevent TAVR-related coronary obstruction; INTERCEPTavi: carbon-dioxide flushing reduces vascular brain injury in TAVI.

Presentations available when logged in:

Outcomes of repeat TAVR with balloon-expandable valves
Five-year outcomes with the Acurate neo2 valve: the Neo AS CE-mark study
TAVR in patients with cardiogenic shock: TVT-registry analysis
Five-year outcomes for TAVI with an intra-annular, self-expandable bioprosthesis
Chimney stenting vs. BASILICA to prevent TAVR-related coronary obstruction
INTERCEPTavi: carbon-dioxide flushing reduces vascular brain injury in TAVI
PORTICO IDE trial: five-year outcomes of Portico vs. commercially available valves

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

EuroPCR 2023 Hotlines / Late-Breaking Trials: TAVI

Session comprising selected EuroPCR 2023 Late-Breaking Trial submissions

Log in or create account for free